Registry study for patients getting TAVI in Italy
Part of Heart & circulation clinical trials.
This study follows people with severe, symptomatic aortic valve narrowing who are planning to get TAVI, a catheter-based valve replacement. It helps doctors and researchers understand what happens to patients after the procedure in Italy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe symptoms from a narrowed native aortic valve
- Your heart care team says you are a candidate for TAVI
- You can understand the study and sign informed consent
- No known reason you cannot safely have TAVI (such as an infection or abnormal clot/mass in the heart)
- You are willing and able to come back for the follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well current treatment choices work for older adults with severe aortic valve narrowing (stenosis). It may help doctors better understand what works best for aging patients in Italy.
This registry is for people with severe, symptomatic aortic valve narrowing who are planning a TAVI procedure (a less invasive valve replacement). It aims to better track and improve how patients do after the valve is replaced, based on how the procedure is planned and performed.
This study is testing a new heart valve system called Hydra, used during a less invasive procedure called TAVI to replace a narrowed heart valve. It may help people with severe aortic stenosis who are already candidates for TAVI.
This trial tests a new heart valve called Hydra for people with severe aortic stenosis who need a valve replacement through a leg artery. It aims to see how well the valve works in real-world patients.
This study is tracking how well the Myval valve works in people with severe aortic stenosis who get it through a minimally invasive procedure called TAVI. It helps doctors learn more about the valve's safety and performance in real-world use.
This study tracks patients who receive a Hydra artificial heart valve to replace a severely narrowed aortic valve. Researchers will follow your progress to understand how well the device works and its safety in real-world use.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.